Percheron Therapeutics LimitedASX: PER

US FDA Feedback on Type C Meeting for ATL1102 in the US

Jun 1, 2021 at 4:19 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment